Cyclooxygenase-2 (COX-2) is an important inducible
enzyme in
inflammation and is overexpressed in a variety of
cancers. Evidence is rapidly accumulating that chronic
inflammation may contribute to
carcinogenesis through increase of cell proliferation, angiogenesis, and
metastasis in a number of
neoplasms, including
colorectal carcinoma. In the present study, we investigated some mechanistic aspects of DFX-induced
hypoxia-driven COX-2 expression.
Desferrioxamine (DFX), an
iron chelator, is known to upregulate inflammatory mediators. DFX induced the expression of COX-2 and accumulation of HIF-1alpha
protein in dose-dependent manners, but
hypoxia mimetic agent
cobalt chloride (CoCl2) induced accumulation of HIF-1alpha
protein but not increase of COX-2 expression. DFX-induced increase of COX-2 expression and HIF-1alpha
protein level was attenuated by addition of
ferric citrate. This result suggested that the
iron chelating function of DFX was important to induce the increase of COX-2 and HIF-1alpha
protein.
PD98059 significantly inhibited the induction of COX-2
protein and accumulation of HIF-1alpha, suggesting that DFX-induced increase of HIF-1alpha and COX-2
protein was mediated, at least in part, through the ERK signaling pathway. In addition, pretreatment with
NS-398 to inhibit COX-2 activity also effectively suppressed DFX-induced HIF-1alpha accumulation in human
colon cancer cells, providing the evidence that COX-2 plays as a regulator of HIF-1alpha accumulation in DFX-treated
colon cancer cells. Together, our findings suggest that
iron metabolism may regulate stabilization of HIF-1alpha
protein by modulating
cyclooxygenase-2 signaling pathway.